Zobrazeno 1 - 10
of 2 428
pro vyhledávání: '"Mohammed Am"'
Autor:
Ishak Ahmed Abdi, Osman Farah Dahir, Ahmed Elmi Abdi, Mohamed Omar Hassan, Said Abdirahman Ahmed, Mohamud Mire Waberi, Ahmed Shafie Aden, Shuayb Moallim Ali Jama, Mohamed Osman Dahir, Can Baba Arın, Mohammed AM Ahmed
Publikováno v:
Radiology Case Reports, Vol 20, Iss 2, Pp 1053-1057 (2025)
Coronary artery aneurysm (CAA) is a rare form of coronary artery disease characterized by abnormal dilation of a coronary artery segment. While CAAs can present with various symptoms, syncope is notably uncommon, with limited documented cases. We pre
Externí odkaz:
https://doaj.org/article/40852c891f6c4c5c9ecdcce327d5a1ab
Autor:
Abdellatif AAH, Ahmed F, Mohammed AM, Alsharidah M, Al-Subaiyel A, Samman WA, Alhaddad AA, Al-Mijalli SH, Amin MA, Barakat H, Osman SK
Publikováno v:
International Journal of Nanomedicine, Vol Volume 18, Pp 3247-3281 (2023)
Ahmed AH Abdellatif,1,2,* Fatma Ahmed,3,* Ahmed M Mohammed,2 Mansour Alsharidah,4 Amal Al-Subaiyel,1 Waad A Samman,5 Aisha A Alhaddad,5 Samiah Hamad Al-Mijalli,6 Mohammed A Amin,1,2 Hassan Barakat,7,8 Shaaban K Osman2,* 1Department of Pha
Externí odkaz:
https://doaj.org/article/9ac31b891a6c461f841625bc80b359c2
Autor:
Salahu D, Abdullahi MM, Abdullahi H, Adeleke N, Adesope S, Aliyu LD, Hassan MM, Alhassan DM, Mamuda A, Abdurrahman A, Adamu SM, Mohammed AM, Ahmed AI, Sadiq GU, Alfa AM, Usman NM, Takai UI
Publikováno v:
Ibom Medical Journal, Vol 15, Iss 3 (2022)
Tranexamic acid (TXA) is a commonly used antifibrinolytic drug during surgical procedures to reduce blood loss. An Inadvertent intrathecal injection of TXA may lead to serious side effects including seizures and ventricular fibrillation with reported
Externí odkaz:
https://doaj.org/article/3dc1b1ec9ae841aca87d90a2a2f01763
Publikováno v:
Journal of Multidisciplinary Healthcare, Vol Volume 14, Pp 961-971 (2021)
Mohamed Ghaith Al-Kuwari,1 Samya Al Abdulla,2 Maha Abdulla,1 Azza Mustafa Mohammed,1 Ahmad Haj Bakri,1 Fahad Shaikhan,3 Hanan Buhaddoud1 1Strategy Planning and Health Intelligence, Primary Health Care Corporation, Doha, Qatar; 2Operations, Primary He
Externí odkaz:
https://doaj.org/article/51adb8f372b44c9e93b4a8f7cd3a2a91
Publikováno v:
Journal of Multidisciplinary Healthcare, Vol Volume 14, Pp 651-657 (2021)
Manal Al-Zaidan,1 Mohamed Izham Mohamed Ibrahim,2 Mohamed Ghaith Al-Kuwari,3 Azza Mustafa Mohammed,3 Mansoor Nawaz Mohammed,4 Samya Al Abdulla5 1Pharmacy Department, Primary Health Care Corporation, Doha, Qatar; 2College of Pharmacy, QU Health, Qatar
Externí odkaz:
https://doaj.org/article/e935059cd6d242ddac67212d84427b0b
Autor:
Obaid, Jamil MAS, Sakran, Khawla AAS, Mohammed, Shaima AH, Al-Salahi, Shifa'a LA, Mahdi, Nawal AN, AL-Sharabi, Mohammed AM, AL-Gaadi, Asadaddin SM, AL-Fatahi, Mohammed NM
Publikováno v:
Journal of Blood Medicine; Oct2024, Vol. 15, p459-469, 11p
Autor:
Khalifa, Mohammed AM1 mmali198939@oiu.edu.sd; mmali198939@gmail.com, Hamad Mohammad, Amna Elhassan2, Ahmed, Basher Mohamed2
Publikováno v:
Pharmaceutical & Biomedical Research. Oct2022, Vol. 8 Issue 4, p279-289. 11p.
Autor:
Abdullah AA Bahmaid, Khalid AM Alotaibi, Omar AJ Aljasser, Abdulrahman M Alharthi, Ashjan YB Almohaimeed, Muath AA Al-Mansour, Renad OA Alhegail, Feras H Alotaibi, Mohammed AM Almuhanna
Publikováno v:
Medical Science. 27:1-10
Autor:
Mohamed Yaqub Hassan, Rahma Yusuf Haji Mohamud, Mohamed Mukhtar Kassim, Ahmed Issak Hussein, Mesut Kayse Adam, Ulaş Emre Akbulut, Ronald Olum, Jerom Okot, Felix Bongomin, Mohammed AM Ahmed
Publikováno v:
IJID Regions.
Autor:
Mark Fung, Aya Haghamad, Elizabeth Montgomery, Kathleen Swanson, Myra L. Wilkerson, Kimon Stathakos, Richard VanNess, Sarah A. Nowak, Clayton Wilburn, Haluk Kavus, Mohammed Amer Swid, Nkemakonam Okoye, Yonah C. Ziemba, Girish Ramrattan, Jonathan Macy, John McConnell, Mary Jane Lewis, Beth Bailey, Khosrow Shotorbani, James M. Crawford
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-14 (2024)
Abstract Background A retrospective observational study was conducted at 3 health care organizations to identify clinical gaps in care for patients with stage 3 or 4 chronic kidney disease (CKD), and financial opportunity from U.S. risk adjustment pa
Externí odkaz:
https://doaj.org/article/66fb86acaf524e25ac1cdde9875bc9c7